 17-alpha-Hydroxyprogesterone
"17-alpha-Hydroxyprogesterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A metabolite of PROGESTERONE with a hydroxyl group at the 17-alpha position. It serves as an intermediate in the biosynthesis of HYDROCORTISONE and GONADAL STEROID HORMONES.
| Descriptor ID |
D019326
|
| MeSH Number(s) |
D04.808.745.745.654.829.395.400 D06.472.334.851.687.750.478.400
|
| Concept/Terms |
17-alpha-Hydroxyprogesterone- 17-alpha-Hydroxyprogesterone
- 17 alpha Hydroxyprogesterone
- 17-Hydroxyprogesterone
- 17 Hydroxyprogesterone
- 17-Hydroxyprogesterone, (17 alpha)-Isomer
- 17 alpha-Hydroxyprogesterone
|
Below are MeSH descriptors whose meaning is more general than "17-alpha-Hydroxyprogesterone".
Below are MeSH descriptors whose meaning is more specific than "17-alpha-Hydroxyprogesterone".
This graph shows the total number of publications written about "17-alpha-Hydroxyprogesterone" by people in this website by year, and whether "17-alpha-Hydroxyprogesterone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 0 | 1 | 1 | | 1985 | 0 | 2 | 2 | | 1987 | 0 | 1 | 1 | | 1991 | 0 | 1 | 1 | | 1992 | 0 | 1 | 1 | | 1993 | 0 | 1 | 1 | | 1994 | 0 | 2 | 2 | | 1997 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 2002 | 1 | 1 | 2 | | 2006 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2014 | 0 | 1 | 1 | | 2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "17-alpha-Hydroxyprogesterone" by people in Profiles.
-
Mimoto MS, Oyler JL, Davis AM. Evaluation and Treatment of Hirsutism in Premenopausal Women. JAMA. 2018 Apr 17; 319(15):1613-1614.
-
Rosenfield RL. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum. J Pediatr Adolesc Gynecol. 2015 Dec; 28(6):412-9.
-
Rosenfield RL, Mortensen M, Wroblewski K, Littlejohn E, Ehrmann DA. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test. Hum Reprod. 2011 Nov; 26(11):3138-46.
-
Mortensen M, Ehrmann DA, Littlejohn E, Rosenfield RL. Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab. 2009 May; 94(5):1579-86.
-
Mortensen M, Rosenfield RL, Littlejohn E. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab. 2006 Oct; 91(10):3786-90.
-
Rosenfield RL. Serum cortisol and 17-hydroxyprogesterone concentrations in children with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2002 Jun; 87(6):2993; author reply 2993.
-
Barnes RB, Namnoum AB, Rosenfield RL, Layman LC. The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum Reprod. 2002 Jan; 17(1):88-91.
-
Barnes RB, Rosenfield RL, Namnoum A, Layman LC. Effect of follicle-stimulating hormone on ovarian androgen production in a woman with isolated follicle-stimulating hormone deficiency. N Engl J Med. 2000 Oct 19; 343(16):1197-8.
-
Levrant SG, Barnes RB, Rosenfield RL. A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism. Hum Reprod. 1997 Jul; 12(7):1416-20.
-
Rosenfield RL, Barnes RB, Ehrmann DA. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994 Dec; 79(6):1686-92.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|